J. Michelot

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Primary Melanomas, Surgical Oncology, Engineering +15

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Engineering, Malignant Melanoma, New Iodine-125 Radiopharmaceuticals +18

Synthesis, characterization and comparative biodistribution study of a new series of p -Iodine-125 benzamides as potential melanoma imaging agents

Nicole Moins, Janine Papon, Hélène Seguin et al. · Nuclear Medicine and Biology · 2001 · 49 citations

Medicinal Chemistry, Engineering, P -Iodine-125 Benzamides +12

Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-Diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents

Marie‐France Moreau, J. Michelot, Janine Papon et al. · Nuclear Medicine and Biology · 1995 · 43 citations

Engineering, Preliminary Evaluation, Medicine +11

Clinical study of [¹²³I] N‐(2‐diethylaminoethyl)‐4‐ iodobenzamide in the diagnosis of primary and metastatic ocular melanoma

F Bacin, J. Michelot, J. Bonafous et al. · Acta Ophthalmologica Scandinavica · 1998 · 20 citations · Full text